What is the price of the Indian version of the generic version of Atropine Sulfate Eye Drops 0.01%? How does it compare to genuine drug prices?
Indian version The price of generic drugs of 0.01% atropine sulfate eye drops (EIKANCE) on the market is relatively affordable, usually selling for about tens of RMB per tube. Compared with genuine drugs, the price gap of generic drugs is significant. Although the ingredients of generic drugs and original drugs are basically the same, the price difference is mainly reflected in production costs and market pricing strategies.
The original drug of atropine sulfate eye drops is not yet on the market in China and is not covered by medical insurance. The price has not yet been determined. However, the selling price of original research drugs overseas is relatively high. The common specifications are 0.01% * 0.3ml * 30 bottles, and the price of each box may be more than 600 yuan. In comparison, the selling price of Indian generic drugs is much lower, especially when the specification is 0.01% w/v * 5ml, its price is significantly lower than that of the original drug.

For patients, the Indian version of the generic version provides an affordable option, especially for those who require long-term use of the drug. Due to their affordability, generic drugs are the first choice for many patients. In addition, Indian manufacturers can often guarantee the quality of drugs. The efficacy and side effects of generic drugs are similar to those of original drugs. Therefore, in most cases, generic drugs can provide the same therapeutic effect as original drugs.
It should be noted that although generic drugs have obvious advantages in price, patients still need to ensure the quality and source of the drugs when purchasing to avoid purchasing fake and shoddy products. Choosing a reputable drug supplier and ensuring that the drug meets relevant quality standards is the key to ensuring treatment effectiveness and safety.
Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)